Has Natalia Biles, MD received payments from drug or device companies?

Yes. Drug and device makers reported $172,497 in general payments to Natalia Biles, MD across 496 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Natalia Biles, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Natalia Biles, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Natalia Biles, MD

Dermatology · Millersville, MDNPI 1588169395

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $156,550 of the $172,497 with a category attached, or 90.8%. Verrica Pharmaceuticals Inc. accounts for 67.1% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2024 at $105,000 and has fallen 51.1% since, to $51,394 in 2025. Among dermatology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$172,497in general payments, 2019–2025

Across 496 payments — averaging $347.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Verrica Pharmaceuticals Inc.$116K
Amgen$46K
Arcutis Biotherapeutics, Inc.$4K
Johnson & Johnson$1K
AbbVie$662
UCB, Inc.$549
plus $4K from 21 others

What the payments were for

Consulting fees$4,2252%
Speaking & faculty fees$156,55091%
Travel & lodging$2,7482%
Food & beverage$8,7935%
Education$1800%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Verrica Pharmaceuticals Inc.	81	$115,805
Amgen	63	$46,050
Arcutis Biotherapeutics, Inc.	9	$4,455
Johnson & Johnson	79	$1,452
AbbVie	29	$662
UCB, Inc.	39	$549
Novartis	26	$491
Lilly USA, LLC	19	$354
E.r. Squibb & Sons, L.L.C.	25	$347
Sanofi	18	$340
Sun Pharmaceutical Industries Inc.	15	$325
Organon	15	$298
Dermavant Sciences, Inc.	27	$271
LEO Pharma Inc.	13	$259
Regeneron Healthcare Solutions, Inc.	7	$175
Incyte Corporation	7	$169
Pfizer	7	$147
Galderma Laboratories, L.p.	4	$71
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$59
Revance Therapeutics, Inc.	1	$34
Boehringer Ingelheim	1	$34
Convatec Inc.	1	$33
Strata Skin Sciences, Inc.	3	$29
Fresenius Kabi USA, LLC	1	$26
ETS Wound Care LLC	1	$23
Biofrontera Inc.	1	$21
LNHC, Inc	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

YCANTH$114,925
Otezla$45,153
ZORYVE$975
Tremfya$137

How this compares

$172,497 in reported general payments places this provider in the 95th percentile of 306 dermatology providers in Maryland.

See all dermatology providers in Maryland →

Medicare billing

Part B allowed, 2024

$156,732

Medicare patients

557

Services billed

2,394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Taltz AutoinjectorIxekizumab	19	$144,954
Clobetasol Propionate	90	$4,318
Ketoconazole	76	$1,827
Fluorouracil	19	$1,604
Triamcinolone Acetonide	101	$1,588
Metronidazole	18	$1,520
Clindamycin Phosphate	22	$926
Tretinoin	16	$910
Doxycycline Hyclate	30	$388
Hydrocortisone	47	$228
Mupirocin	22	$209
Prednisone	11	$88

Paid to pharmacies, not to this prescriber.

Other dermatology in Millersville

Sammy KangMillersville$11K
Benjamin LockshinSilver Spring$4M
Shawn KwatraBaltimore$1.1M
Chesahna Kindred WeaverMarriottsville$837K
Oanh LauringNottingham$763K
Ronald PrussickN Bethesda$620K
Rebecca KazinChevy Chase$342K
Susan WalkerBethesda$221K
Monte MeltzerBerlin$220K
Valerie CallenderGlenn Dale$183K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →